Quest Diagnostic Receives the US FDA’s First EUA for Sample Pooling in COVID-19

July 20, 2020 Auto Bot Diagnostics, EUA, FDA, First, Latest, receives 0

Shots:

  • The US FDA has authorized Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to 4 individual swab specimens collected under observation. The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples
  • Quest Diagnostic expects to deploy the technique at its laboratories in Chantilly, VA and Marlborough, Mass., by the end of next week with additional laboratories to follow
  • The company has received the FDA’s EUA for use of self-collection molecular diagnostic kit on the Hologic and Roche’s platforms, expanding use with healthcare provider supervision via telemedicine

Click here to read full press release/ article | Ref: PRNewswire | Image: Glassdoor